|
New York
|
001-33861
|
11-2153962
|
||
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
2929 California Street, Torrance, CA
|
90503
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
| ☐ |
Soliciting material pursuant to Rule l4a-12 under the Exchange Act (17 CFR 240.l4a-12)
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common Stock, par value $0.01 per share
|
MPAA
|
The Nasdaq Global Select Market
|
| Item 2.02. |
Results of Operations and Financial Condition
|
| Item 9.01. |
Financial Statements and Exhibits.
|
|
Exhibit No.
|
Description
|
| 99.1 |
Press Release, dated June 15, 2020 |
|
MOTORCAR PARTS OF AMERICA, INC.
|
||
|
Date: June 15, 2020
|
/s/ David Lee
|
|
|
David Lee
|
||
|
Chief Financial Officer
|
||

|
Motorcar Parts of America, Inc.
2-2-2
|
|
Motorcar Parts of America, Inc.
3-3-3
|
|
Motorcar Parts of America, Inc.
4-4-4
|
|
Motorcar Parts of America, Inc.
5-5-5
|
|
Three Months Ended March 31,
|
Twelve Months Ended March 31,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
(Unaudited)
|
||||||||||||||||
|
Net sales
|
$
|
150,735,000
|
$
|
129,077,000
|
$
|
535,831,000
|
$
|
472,797,000
|
||||||||
|
Cost of goods sold
|
114,152,000
|
103,127,000
|
417,431,000
|
383,623,000
|
||||||||||||
|
Gross profit
|
36,583,000
|
25,950,000
|
118,400,000
|
89,174,000
|
||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
General and administrative
|
34,522,000
|
12,553,000
|
71,425,000
|
45,972,000
|
||||||||||||
|
Sales and marketing
|
5,047,000
|
5,464,000
|
21,037,000
|
19,542,000
|
||||||||||||
|
Research and development
|
2,506,000
|
2,440,000
|
9,200,000
|
8,014,000
|
||||||||||||
|
Total operating expenses
|
42,075,000
|
20,457,000
|
101,662,000
|
73,528,000
|
||||||||||||
|
Operating (loss) income
|
(5,492,000
|
)
|
5,493,000
|
16,738,000
|
15,646,000
|
|||||||||||
|
Interest expense, net
|
5,464,000
|
6,689,000
|
25,039,000
|
23,227,000
|
||||||||||||
|
Loss before income tax (benefit) expense
|
(10,956,000
|
)
|
(1,196,000
|
)
|
(8,301,000
|
)
|
(7,581,000
|
)
|
||||||||
|
Income tax (benefit) expense
|
(2,763,000
|
)
|
1,569,000
|
(1,011,000
|
)
|
268,000
|
||||||||||
|
Net loss
|
$
|
(8,193,000
|
)
|
$
|
(2,765,000
|
)
|
$
|
(7,290,000
|
)
|
$
|
(7,849,000
|
)
|
||||
|
Basic net loss per share
|
$
|
(0.43
|
)
|
$
|
(0.15
|
)
|
$
|
(0.39
|
)
|
$
|
(0.42
|
)
|
||||
|
Diluted net loss per share
|
$
|
(0.43
|
)
|
$
|
(0.15
|
)
|
$
|
(0.39
|
)
|
$
|
(0.42
|
)
|
||||
|
Weighted average number of shares outstanding:
|
||||||||||||||||
|
Basic
|
18,967,865
|
18,814,133
|
18,913,788
|
18,849,909
|
||||||||||||
|
Diluted
|
18,967,865
|
18,814,133
|
18,913,788
|
18,849,909
|
||||||||||||
|
March 31, 2020
|
March 31, 2019
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
49,616,000
|
$
|
9,911,000
|
||||
|
Short-term investments
|
850,000
|
3,273,000
|
||||||
|
Accounts receivable — net
|
91,748,000
|
56,015,000
|
||||||
|
Inventory — net
|
225,659,000
|
233,726,000
|
||||||
|
Inventory unreturned
|
9,021,000
|
8,469,000
|
||||||
|
Contract assets
|
20,332,000
|
22,183,000
|
||||||
|
Income tax receivable
|
3,282,000
|
10,009,000
|
||||||
|
Prepaid expenses and other current assets
|
8,608,000
|
9,296,000
|
||||||
|
Total current assets
|
409,116,000
|
352,882,000
|
||||||
|
Plant and equipment — net
|
44,957,000
|
35,151,000
|
||||||
|
Operating lease assets
|
53,029,000
|
-
|
||||||
|
Long-term deferred income taxes
|
18,950,000
|
9,746,000
|
||||||
|
Long-term contract assets
|
239,540,000
|
221,876,000
|
||||||
|
Goodwill
|
3,205,000
|
3,205,000
|
||||||
|
Intangible assets — net
|
6,393,000
|
8,431,000
|
||||||
|
Other assets
|
1,839,000
|
1,071,000
|
||||||
|
TOTAL ASSETS
|
$
|
777,029,000
|
$
|
632,362,000
|
||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$
|
78,664,000
|
$
|
92,461,000
|
||||
|
Accrued liabilities
|
16,419,000
|
14,604,000
|
||||||
|
Customer finished goods returns accrual
|
25,326,000
|
22,615,000
|
||||||
|
Contract liabilities
|
27,911,000 |
30,599,000
|
||||||
|
Revolving loan
|
152,000,000
|
110,400,000
|
||||||
|
Other current liabilities
|
9,390,000
|
4,990,000
|
||||||
|
Operating lease liabilities
|
5,104,000
|
-
|
||||||
|
Current portion of term loan
|
3,678,000
|
3,685,000
|
||||||
|
Total current liabilities
|
318,492,000 |
279,354,000
|
||||||
|
Term loan, less current portion
|
20,462,000
|
24,187,000
|
||||||
|
Long-term contract liabilities
|
92,101,000 |
40,889,000
|
||||||
|
Long-term deferred income taxes
|
79,000
|
257,000
|
||||||
|
Long-term operating lease liabilities
|
61,425,000
|
-
|
||||||
|
Other liabilities
|
8,950,000
|
7,920,000
|
||||||
|
Total liabilities
|
501,509,000
|
352,607,000
|
||||||
|
Commitments and contingencies
|
||||||||
|
Shareholders' equity:
|
||||||||
|
Preferred stock; par value $.01 per share, 5,000,000 shares authorized; none issued
|
-
|
-
|
||||||
|
Series A junior participating preferred stock; par value $.01 per share, 20,000 shares authorized; none issued
|
-
|
-
|
||||||
|
Common stock; par value $.01 per share, 50,000,000 shares authorized; 18,969,380 and 18,817,400 shares issued and outstanding at March 31, 2020 and 2019, respectively
|
190,000
|
188,000
|
||||||
|
Additional paid-in capital
|
218,581,000
|
215,047,000
|
||||||
|
Retained earnings
|
64,117,000
|
71,407,000
|
||||||
|
Accumulated other comprehensive loss
|
(7,368,000
|
)
|
(6,887,000
|
)
|
||||
|
Total shareholders' equity
|
275,520,000
|
279,755,000
|
||||||
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
$
|
777,029,000
|
$
|
632,362,000
|
||||
|
Items Impacting Net Loss for the Three Months Ended March 31, 2020
|
Exhibit 1 |
|
Three Months Ended March 31,
|
||||||||||||||||
|
2020
|
2019
|
|||||||||||||||
| $ |
Per Share
|
$ |
Per Share
|
|||||||||||||
|
GAAP net loss
|
$
|
(8,193,000
|
)
|
$
|
(0.43
|
)
|
$
|
(2,765,000
|
)
|
$
|
(0.15
|
)
|
||||
|
Items impacting net loss
|
||||||||||||||||
|
Customer allowances, return accruals and changeover costs (a) related to new business and product line expansion, net of costs
|
(54,000
|
)
|
(0.00
|
)
|
2,260,000
|
0.12
|
||||||||||
|
Core buy-back premium amortization
|
958,000
|
0.05
|
1,093,000
|
0.06
|
||||||||||||
|
New product line start-up costs and transition expenses (b)
|
2,816,000
|
0.15
|
3,384,000
|
0.18
|
||||||||||||
|
Revaluation - cores on customers' shelves
|
932,000
|
0.05
|
7,377,000
|
0.39
|
||||||||||||
|
Inventory step-up amortization
|
-
|
-
|
104,000
|
0.01
|
||||||||||||
|
Acquisition costs and earn-out accruals, financing, severance, and restatement-related fees
|
(553,000
|
)
|
(0.03
|
)
|
1,253,000
|
0.07
|
||||||||||
|
Share-based compensation expenses
|
1,029,000
|
0.05
|
2,413,000
|
0.13
|
||||||||||||
|
Mark-to-market losses (gains)
|
20,708,000
|
1.09
|
(656,000
|
)
|
(0.03
|
)
|
||||||||||
|
Tax effect (c)
|
(6,459,000
|
)
|
(0.34
|
)
|
(4,307,000
|
)
|
(0.23
|
)
|
||||||||
| Items Impacting Net Loss for the Twelve Months Ended March 31, 2020 | Exhibit 2 |
|
Twelve Months Ended March 31,
|
||||||||||||||||
|
2020
|
2019
|
|||||||||||||||
| $ |
Per Share
|
$ |
Per Share
|
|||||||||||||
|
GAAP net loss
|
$
|
(7,290,000
|
)
|
$
|
(0.39
|
)
|
$
|
(7,849,000
|
)
|
$
|
(0.42
|
)
|
||||
|
Items impacting net loss
|
||||||||||||||||
|
Customer allowances, return accruals and changeover costs (a) related to new business and product line expansion, net of costs
|
1,177,000
|
0.06
|
6,907,000
|
0.37
|
||||||||||||
|
Core buy-back premium amortization
|
4,501,000
|
0.24
|
4,126,000
|
0.22
|
||||||||||||
|
Impact of tariff costs before being passed through to customers
|
1,067,000
|
0.06
|
1,526,000
|
0.08
|
||||||||||||
|
Loss in connection with a cancelled contract
|
133,000
|
0.01
|
764,000
|
0.04
|
||||||||||||
|
New product line start-up costs and transition expenses (b)
|
10,281,000
|
0.54
|
10,528,000
|
0.56
|
||||||||||||
|
Revaluation - cores on customers' shelves
|
10,799,000
|
0.57
|
18,843,000
|
1.00
|
||||||||||||
|
Inventory step-up amortization
|
-
|
-
|
104,000
|
0.01
|
||||||||||||
|
Acquisition costs and earn-out accruals, financing, severance, and restatement-related fees
|
(261,000
|
)
|
(0.01
|
)
|
2,296,000
|
0.12
|
||||||||||
|
Share-based compensation expenses
|
4,141,000
|
0.22
|
5,564,000
|
0.30
|
||||||||||||
|
Mark-to-market losses (gains)
|
18,201,000
|
0.96
|
972,000
|
0.05
|
||||||||||||
|
Write-off of debt issuance costs
|
-
|
-
|
303,000
|
0.02
|
||||||||||||
|
Tax effect (c)
|
(12,510,000
|
)
|
(0.66
|
)
|
(12,983,000
|
)
|
(0.69
|
)
|
||||||||
| Items Impacting Gross Profit for the Three Months Ended March 31, 2020 | Exhibit 3 |
|
Three Months Ended March 31,
|
||||||||||||||||
|
2020
|
2019
|
|||||||||||||||
| $ |
Gross Margin
|
$ |
Gross Margin
|
|||||||||||||
|
GAAP gross profit
|
$
|
36,583,000
|
24.3
|
%
|
$
|
25,950,000
|
20.1
|
%
|
||||||||
|
Adjustments:
|
||||||||||||||||
|
New product line start-up costs and transition expenses
|
2,508,000
|
1.7
|
%
|
2,512,000
|
1.9
|
%
|
||||||||||
|
Revaluation - cores on customers' shelves
|
932,000
|
0.6
|
%
|
7,377,000
|
5.7
|
%
|
||||||||||
|
Loss related to under return of cores
|
215,000
|
0.1
|
%
|
716,000
|
0.6
|
%
|
||||||||||
|
Total adjustments
|
3,655,000
|
2.4
|
%
|
10,605,000
|
8.2
|
%
|
||||||||||
|
Adjusted gross profit (a)
|
$
|
40,238,000
|
26.7
|
%
|
$
|
36,555,000
|
28.3
|
%
|
||||||||
|
Other items not adjusted
|
||||||||||||||||
|
Customer allowances and return accruals related to new business and product line expansion, net of costs
|
(54,000
|
)
|
0.0
|
%
|
1,959,000
|
1.5
|
%
|
|||||||||
|
Core buy-back premium amortization
|
958,000
|
0.6
|
%
|
1,093,000
|
0.8
|
%
|
||||||||||
|
Inventory step-up amortization
|
-
|
-
|
104,000
|
0.1
|
%
|
|||||||||||
| Items Impacting Gross Profit for the Twelve Months Ended March 31, 2020 | Exhibit 4 |
|
Twelve Months Ended March 31,
|
||||||||||||||||
|
2020
|
2019
|
|||||||||||||||
| $ |
Gross Margin
|
$ |
Gross Margin
|
|||||||||||||
|
GAAP gross profit
|
$
|
118,400,000
|
22.1
|
%
|
$
|
89,174,000
|
18.9
|
%
|
||||||||
|
Adjustments:
|
||||||||||||||||
|
New product line start-up costs and transition expenses
|
8,337,000
|
1.6
|
%
|
8,178,000
|
1.7
|
%
|
||||||||||
|
Revaluation - cores on customers' shelves
|
10,799,000
|
2.0
|
%
|
18,843,000
|
4.0
|
%
|
||||||||||
|
(Income) loss related to under return of cores
|
(1,609,000
|
)
|
-0.3
|
%
|
962,000
|
0.2
|
%
|
|||||||||
|
Total adjustments
|
17,527,000
|
3.3
|
%
|
27,983,000
|
5.9
|
%
|
||||||||||
|
Adjusted gross profit (a)
|
$
|
135,927,000
|
25.4
|
%
|
$
|
117,157,000
|
24.8
|
%
|
||||||||
|
Other items not adjusted
|
||||||||||||||||
|
Customer allowances and return accruals related to new business and product line expansion, net of costs
|
1,065,000
|
0.2
|
%
|
6,042,000
|
1.3
|
%
|
||||||||||
|
Core buy-back premium amortization
|
4,501,000
|
0.8
|
%
|
4,126,000
|
0.9
|
%
|
||||||||||
|
Impact of tariff costs before being passed through to customers
|
1,067,000
|
0.2
|
%
|
1,526,000
|
0.3
|
%
|
||||||||||
|
Loss in connection with a cancelled contract
|
133,000
|
0.0
|
%
|
764,000
|
0.2
|
%
|
||||||||||
|
Inventory step-up amortization
|
-
|
104,000
|
0.0
|
%
|
||||||||||||
|
Items Impacting EBITDA for the Three and Twelve Months Ended March 31, 2020
|
Exhibit 5
|
|
Three Months Ended March 31,
|
Twelve Months Ended March 31,
|
|||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
GAAP net loss
|
$
|
(8,193,000
|
)
|
$
|
(2,765,000
|
)
|
$
|
(7,290,000
|
)
|
$
|
(7,849,000
|
)
|
||||
|
Interest expense, net
|
5,464,000
|
6,689,000
|
25,039,000
|
23,227,000
|
||||||||||||
|
Income tax (benefit) expense
|
(2,763,000
|
)
|
1,569,000
|
(1,011,000
|
)
|
268,000
|
||||||||||
|
Depreciation and amortization
|
2,542,000
|
2,396,000
|
9,561,000
|
7,329,000
|
||||||||||||
|
EBITDA
|
$
|
(2,950,000
|
)
|
$
|
7,889,000
|
$
|
26,299,000
|
$
|
22,975,000
|
|||||||
|
Items impacting EBITDA
|
||||||||||||||||
|
Customer allowances, return accruals and changeover costs related to new business and product line expansion, net of costs
|
(54,000
|
)
|
2,260,000
|
1,177,000
|
6,907,000
|
|||||||||||
|
Core buy-back premium amortization
|
958,000
|
1,093,000
|
4,501,000
|
4,126,000
|
||||||||||||
|
Impact of tariff costs before being passed through to customers
|
-
|
-
|
1,067,000
|
1,526,000
|
||||||||||||
|
Loss in connection with a cancelled contract
|
-
|
-
|
133,000
|
764,000
|
||||||||||||
|
New product line start-up costs and transition expenses (a)
|
2,752,000
|
3,095,000
|
9,998,000
|
9,712,000
|
||||||||||||
|
Revaluation - cores on customers' shelves
|
932,000
|
7,377,000
|
10,799,000
|
18,843,000
|
||||||||||||
|
Inventory step-up amortization
|
-
|
104,000
|
-
|
104,000
|
||||||||||||
|
Acquisition costs and earn-out accruals, financing, severance, and restatement-related fees
|
(553,000
|
)
|
1,253,000
|
(261,000
|
)
|
2,296,000
|
||||||||||
|
Share-based compensation expenses
|
1,029,000
|
2,413,000
|
4,141,000
|
5,564,000
|
||||||||||||
|
Mark-to-market losses (gains)
|
20,708,000
|
(656,000
|
)
|
18,201,000
|
972,000
|
|||||||||||